Diagnostic Laparoscopy of Patient with Deep Vein Thrombosis before Diagnosis of Ovarian Cancer : A Case Report

Ha, Jae Eun; Lee, Yong Seok; Lee, Hae Nam; Park, Eun Kyung

doi:10.4143/crt.2010.42.1.48

Cited by 3 publications

(3 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Based on these circumstances, optimal cytoreductive surgery was performed without placement of a preoperative IVC filter. This case differed from those of previous studies (20,21). The patient was followed up for >3 years, during which time serum tumor marker assays and TVS scans identified no evidence of tumor recurrence.…”

Section: Discussioncontrasting

confidence: 65%

“…There are currently three approaches to the management of such cases: i) Up-front primary cytoreductive surgery with placement of an IVC filter prior to surgery to prevent PE (20); ii) neoadjuvant chemotherapy followed by interval debulking surgery for huge tumors that cannot be treated with optimal primary cytoreductive surgery (20); and iii) initial less-invasive diagnostic laparoscopy to remove cancer tissue, followed by three cycles of chemotherapy and complete staging surgery, an approach restricted to patients with small ovarian tumors (21). Up-front primary cytoreductive surgery with preoperative IVC filter placement provides a histopathological diagnosis, removes as much cancer tissue as possible, establishes the International Federation of Gynecology and Obstetrics stage (2), aids complete resection of macroscopic disease (22) and improves overall survival (20,23), compared with the effects of neoadjuvant chemotherapy for resectable advanced ovarian cancer.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Optimal cytoreductive surgery for underlying ovarian cancer associated with deep venous thrombosis without placement of inferior vena cava filter: A case report and literature review

et al. 2015

View full text Add to dashboard Cite

Abstract. Ovarian cancer associated with deep venous thrombosis (DVT) is an uncommon, potentially life-threatening condition. The primary therapeutic strategy for the treatment of this condition is up-front primary cytoreductive surgery, with placement of an inferior vena cava (IVC) filter prior to surgery to prevent fatal pulmonary embolism. The present study describes the case of a 49-year-old female, who presented with DVT unresponsive to anticoagulant therapy in the lower extremities prior to the diagnosis of ovarian cancer. During the search for the underlying malignancy, transvaginal sonography (TVS) revealed a cystic solid mass in the pelvic cavity. Subsequently, the patient underwent up-front primary cytoreductive surgery without placement of a preoperative IVC filter, followed by six cycles of chemotherapy. The patient was diagnosed with ovarian clear cell adenocarcinoma stage IIIC, complicated by DVT, and had survived >3 years without relapse at the time of completion of the present study. The successful outcome of the present case demonstrated that occult primary cancer should be suspected in patients with DVT unresponsive to anticoagulant therapy. The present study also indicated that up-front primary cytoreductive surgery without placement of an IVC filter represents an effective potential strategy for the treatment of advanced ovarian cancer associated with DVT, as the thrombus strongly adheres to the vessel wall following organization.

show abstract

Section: Discussioncontrasting

confidence: 65%

Section: Discussionmentioning

confidence: 99%

Optimal cytoreductive surgery for underlying ovarian cancer associated with deep venous thrombosis without placement of inferior vena cava filter: A case report and literature review

et al. 2015

View full text Add to dashboard Cite

show abstract

“…Venous thrombosis of the lower extremities is the most common adverse event after laparoscopic treatment [ 10 ]. DVT occurs when a blood clot forms in the vein of the leg.…”

Section: Introductionmentioning

confidence: 99%

Analysis of the Preventive Action of Rivaroxaban against Lower Extremity Deep Venous Thrombosis in Patients after Laparoscopic Radical Gastrectomy

Dong

Zhu

Gao

et al. 2022

Computational and Mathematical Methods in Medicine

View full text Add to dashboard Cite

Background. Gastric carcinoma (GC) is a common lethal cancer in the world. Patients are prone to develop lower extremity deep venous thrombosis (LEDVT) after laparoscopic radical gastrectomy (LRG), which threatens their life and health. Purpose. This research is to clarify the preventive action of rivaroxaban (Riv) against LEDVT in patients undergoing LRG. Methods. A retrospective study was conducted on 70 patients with GC admitted for LRG between January 2019 and January 2022, including 40 patients (observation group) receiving Riv treatment and 30 patients (conventional group) treated with air wave pressure therapy apparatus. Quality of life, coagulation function, LEDVT formation, and complications were compared between groups. Results. The observation group had better recovery of life quality than the control group, along with more effective inhibition of coagulation disorders, less DVT formation, and fewer complications. Conclusions. Compared with air wave pressure therapy apparatus, Riv has better preventive action against LEDVT in GC patients after LRG.

show abstract

Increase in Carbohydrate Antigen 19-9 Levels without Tumor Progression after Polaprezinc Administration that Induced Deep Vein Thrombosis in a Colon Cancer Patient

et al. 2019

View full text Add to dashboard Cite

Carbohydrate antigen 19-9 (CA 19-9) is a well-known tumor marker of adenocarcinoma (reference range, 37 U/mL). It can also be used, together with computed tomography, to monitor responses and resistance to chemotherapy in cancer patients. False elevation of CA 19-9 levels is often seen in conditions such as biliary tract obstruction and cholangitis. However, whether medication might induce false elevation of CA 19-9 levels has not yet been reported. A 74-year-old man was treated with third-line CPT-11 (irinotecan) plus panitumumab for stage IV cancer of the ascending colon. The patient developed chemotherapy-induced dysgeusia and was treated with polaprezinc. After polaprezinc administration, his CA 19-9 levels gradually increased from 18.9 to 1,699.4 U/mL. He developed deep vein thrombosis (DVT), although it was not associated with progressive disease or metastasis. Upon discontinuation of polaprezinc, CA 19-9 levels gradually decreased. This case demonstrates that polaprezinc may not only induce false elevation of CA 19-9 levels but also cause development of DVT induced by increased CA 19-9 levels, both of which are very rare events.

show abstract

Diagnostic Laparoscopy of Patient with Deep Vein Thrombosis before Diagnosis of Ovarian Cancer : A Case Report

Cited by 3 publications

References 13 publications

Optimal cytoreductive surgery for underlying ovarian cancer associated with deep venous thrombosis without placement of inferior vena cava filter: A case report and literature review

Optimal cytoreductive surgery for underlying ovarian cancer associated with deep venous thrombosis without placement of inferior vena cava filter: A case report and literature review

Analysis of the Preventive Action of Rivaroxaban against Lower Extremity Deep Venous Thrombosis in Patients after Laparoscopic Radical Gastrectomy

Increase in Carbohydrate Antigen 19-9 Levels without Tumor Progression after Polaprezinc Administration that Induced Deep Vein Thrombosis in a Colon Cancer Patient

Contact Info

Product

Resources

About